Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 2919-2929

  Ndungu, Francis M ^a,d   Lundblom, Klara ^b   Rono, Josea ^a,b   Illingworth, Joseph ^d   Eriksson, Sara ^b,c   Färnert, Anna ^b,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibodies; Longevity; Malaria; Memory B cells; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; MEROZOITE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 3; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KENYA; MALARIA CONTROL; MALARIA FALCIPARUM; MEMORY CELL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SWEDEN; TRAVEL;

ANTIBODIES; LONGEVITY; MALARIA; MEMORY B CELLS; PLASMODIUM FALCIPARUM;

ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALARIA, FALCIPARUM; MALE; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MEROZOITES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; QUESTIONNAIRES; SWEDEN; TRAVEL;

EID: 84888073939     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343630     Document Type: Article

References (61)

1. Langhorne, J., Ndungu, F. M., Sponaas, A. M. and Marsh, K., Immunity to malaria: more questions than answers. Nat. Immunol. 2008. 9: 725-732.
2. Marsh, K., Malaria-a neglected disease? Parasitology 1992. 104(Suppl): S53-S69.
3. Marsh, K. and Kinyanjui, S., Immune effector mechanisms in malaria. Parasite Immunol. 2006. 28: 51-60.
4. Ghani, A. C., Sutherland, C. J., Riley, E. M., Drakeley, C. J., Griffin, J. T., Gosling, R. D. and Filipe, J. A., Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends. PLoS One 2009. 4: e4383.
5. Bejon, P., Ogada, E., Peshu, N. and Marsh, K., Interactions between age and ITN use determine the risk of febrile malaria in children. PLoS One 2009. 4: e8321.
6. Aponte, J. J., Menendez, C., Schellenberg, D., Kahigwa, E., Mshinda, H., Vountasou, P., Tanner, M. et al., Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 2007. 4: e242.
7. Kleinschmidt, I., Schwabe, C., Benavente, L., Torrez, M., Ridl, F. C., Segura, J. L., Ehmer, P. et al., Marked increase in child survival after four years of intensive malaria control. Am. J. Trop. Med. Hyg. 2009. 80: 882-888.
8. Cohen, S., Mc, G. I. and Carrington, S., Gamma-globulin and acquired immunity to human malaria. Nature 1961. 192: 733-737.
9. Fowkes, F. J., Richards, J. S., Simpson, J. A. and Beeson, J. G., The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis. PLoS Med. 2010. 7: e1000218.
10. Sabchareon, A., Burnouf, T., Ouattara, D., Attanath, P., Bouharoun-Tayoun, H., Chantavanich, P., Foucault, C. et al., Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 1991. 45: 297-308.
11. Akpogheneta, O. J., Duah, N. O., Tetteh, K. K., Dunyo, S., Lanar, D. E., Pinder, M. and Conway, D. J., Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect. Immun. 2008. 76: 1748-1755.
12. Cavanagh, D. R., Elhassan, I. M., Roper, C., Robinson, V. J., Giha, H., Holder, A. A., Hviid, L. et al., A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J. Immunol. 1998. 161: 347-359.
13. Kinyanjui, S. M., Bull, P., Newbold, C. I. and Marsh, K., Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J. Infect. Dis. 2003. 187: 667-674.
14. Branch, O. H., Takala, S., Kariuki, S., Nahlen, B. L., Kolczak, M., Hawley, W. and Lal, A. A., Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project. Infect. Immun. 2001. 69: 7783-7792.
15. Fruh, K., Doumbo, O., Muller, H. M., Koita, O., McBride, J., Crisanti, A., Toure, Y. et al., Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect. Immun. 1991. 59: 1319-1324.
16. Drakeley, C. J., Carneiro, I., Reyburn, H., Malima, R., Lusingu, J. P., Cox, J., Theander, T. G. et al., Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. J. Infect. Dis. 2005. 191: 1589-1598.
17. Taylor, R. R., Egan, A., McGuinness, D., Jepson, A., Adair, R., Drakely, C. and Riley, E., Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int. Immunol. 1996. 8: 905-915.
18. Illingworth, J., Butler, N. S., Roetynck, S., Mwacharo, J., Pierce, S. K., Bejon, P., Crompton, P. D. et al., Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J. Immunol. 2013. 190: 1038-1047.
19. Weiss, G. E., Clark, E. H., Li, S., Traore, B., Kayentao, K., Ongoiba, A., Hernandez, J. N. et al., A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS One 2011. 6: e15983.
20. Weiss, G. E., Crompton, P. D., Li, S., Walsh, L. A., Moir, S., Traore, B., Kayentao, K. et al., Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 2009. 183: 2176-2182.
21. Fogli, M., Torti, C., Malacarne, F., Fiorentini, S., Albani, M., Izzo, I., Giagulli, C. et al., Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naive for HAART is related to reduced immune surveillance. Clin. Dev. Immunol. 2012. 2012: 829584.
22. Moir, S., Ho, J., Malaspina, A., Wang, W., DiPoto, A. C., O'Shea, M. A., Roby, G. et al., Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008. 205: 1797-1805.
23. Muellenbeck, M. F., Ueberheide, B., Amulic, B., Epp, A., Fenyo, D., Busse, C. E., Esen, M. et al., Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 2013. 210: 389-399.
24. Bernasconi, N. L., Traggiai, E. and Lanzavecchia, A., Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002. 298: 2199-2202.
25. Bottiger, M., Gustavsson, O. and Svensson, A., Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991. Int. J. Epidemiol. 1998. 27: 916-925.
26. Crotty, S. and Ahmed, R., Immunological memory in humans. Semin. Immunol. 2004. 16: 197-203.
27. Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L. and Ahmed, R., Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 2003. 171: 4969-4973.
28. Banatvala, J., Van Damme, P. and Oehen, S., Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2000. 19: 877-885.
29. Bauer, T. and Jilg, W., Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006. 24: 572-577.
30. Wainwright, R. B., Bulkow, L. R., Parkinson, A. J., Zanis, C. and McMahon, B. J., Protection provided by hepatitis B vaccine in a Yupik Eskimo population-results of a 10-year study. J. Infect. Dis. 1997. 175: 674-677.
31. West, D. J. and Calandra, G. B., Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996. 14: 1019-1027.
32. Jilg, W., Schmidt, M. and Deinhardt, F., Decline of anti-HBs after hepatitis B vaccination and timing of revaccination. Lancet 1990. 335: 173-174.
33. Guan, Y., Sajadi, M. M., Kamin-Lewis, R., Fouts, T. R., Dimitrov, A., Zhang, Z., Redfield, R. R. et al., Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proc. Natl. Acad. Sci. USA 2009. 106: 3952-3957.
34. Vande Waa, J. A., Jensen, J. B., Akood, M. A. and Bayoumi, R., Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan. Infect. Immun. 1984. 45: 505-510.
35. Migot, F., Chougnet, C., Raharimalala, L., Astagneau, P., Lepers, J. P. and Deloron, P., Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar. Am. J. Trop. Med. Hyg. 1993. 48: 432-439.
36. Clark, E. H., Silva, C. J., Weiss, G. E., Li, S., Padilla, C., Crompton, P. D., Hernandez, J. N. et al., Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect. Immun. 2012. 80: 1583-1592.
37. Ndungu, F. M., Cadman, E. T., Coulcher, J., Nduati, E., Couper, E., Macdonald, D. W., Ng, D. et al., Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice. PLoS Pathog. 2009. 5: e1000690.
38. Wipasa, J., Suphavilai, C., Okell, L. C., Cook, J., Corran, P. H., Thaikla, K., Liewsaree, W. et al., Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog. 2010. 6: e1000770.
39. Ndungu, F. M., Olotu, A., Mwacharo, J., Nyonda, M., Apfeld, J., Mramba, L. K., Fegan, G. W. et al., Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc. Natl. Acad. Sci. USA 2012. 109: 8247-8252.
40. Weiss, G. E., Traore, B., Kayentao, K., Ongoiba, A., Doumbo, S., Doumtabe, D., Kone, Y. et al., The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 2010. 6: e1000912.
41. Nogaro, S. I., Hafalla, J. C., Walther, B., Remarque, E. J., Tetteh, K. K., Conway, D. J., Riley, E. M. et al., The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission. PLoS One 2011. 6: e25582.
42. Eisen, D. P., Wang, L., Jouin, H., Murhandarwati, E. E., Black, C. G., Mercereau-Puijalon, O. and Coppel, R. L., Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals. Malar. J. 2007. 6: 86.
43. Elliott, S. R., Payne, P. D., Duffy, M. F., Byrne, T. J., Tham, W. H., Rogerson, S. J., Brown, G. V. et al., Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults. Am. J. Trop. Med. Hyg. 2007. 76: 860-864.
44. Pierce, S. K., Understanding B cell activation: from single molecule tracking, through Tolls, to stalking memory in malaria. Immunol. Res. 2008. 43: 85-97.
45. Struik, S. S. and Riley, E. M., Does malaria suffer from lack of memory? Immunol. Rev. 2004. 201: 268-290.
46. Stephens, R., Ndungu, F. M. and Langhorne, J., Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells. Parasite Immunol. 2009. 31: 20-31.
47. Crompton, P. D., Mircetic, M., Weiss, G., Baughman, A., Huang, C. Y., Topham, D. J., Treanor, J. J. et al., The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J. Immunol. 2009. 182: 3318-3326.
48. Bouchaud, O., Cot, M., Kony, S., Durand, R., Schiemann, R., Ralaimazava, P., Coulaud, J. P. et al., Do African immigrants living in France have long-term malarial immunity? Am. J. Trop. Med. Hyg. 2005. 72: 21-25.
49. Teirlinck, A. C., McCall, M. B., Roestenberg, M., Scholzen, A., Woestenenk, R., de Mast, Q., van der Ven, A. J. et al., Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011. 7: e1002389.
50. Ceesay, S. J., Casals-Pascual, C., Erskine, J., Anya, S. E., Duah, N. O., Fulford, A. J., Sesay, S. S. et al., Changes in malaria indices betewen 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008. 372: 1545-1554.
51. O'Meara, W. P., Noor, A., Gatakaa, H., Tsofa, B., McKenzie, F. E. and Marsh, K., The impact of primary health care on malaria morbidity-defining access by disease burden. Trop. Med. Int. Health 2009. 14: 29-35.
52. Okiro, E. A., Hay, S. I., Gikandi, P. W., Sharif, S. K., Noor, A. M., Peshu, N., Marsh, K. et al., The decline in paediatric malaria admissions on the coast of Kenya. Malar. J. 2007. 6: 151.
53. Combe, A., Giovannini, D., Carvalho, T. G., Spath, S., Boisson, B., Loussert, C., Thiberge, S. et al., Clonal conditional mutagenesis in malaria parasites. Cell Host Microbe 2009. 5: 386-396.
54. Bejon, P., Mwacharo, J., Kai, O., Todryk, S., Keating, S., Lowe, B., Lang, T. et al., The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J. Immunol. 2007. 179: 4193-4201.
55. Mbogo, C. M., Mwangangi, J. M., Nzovu, J., Gu, W., Yan, G., Gunter, J. T., Swalm, C. et al., Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am. J. Trop. Med. Hyg. 2003. 68: 734-742.
56. Osier, F. H., Fegan, G., Polley, S. D., Murungi, L., Verra, F., Tetteh, K. K., Lowe, B. et al., Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 2008. 76: 2240-2248.
57. Polley, S. D., Conway, D. J., Cavanagh, D. R., McBride, J. S., Lowe, B. S., Williams, T. N., Mwangi, T. W. et al., High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006. 24: 4233-4246.
58. Polley, S. D., Mwangi, T., Kocken, C. H., Thomas, A. W., Dutta, S., Lanar, D. E., Remarque, E. et al., Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 2004. 23: 718-728.
59. Polley, S. D., Tetteh, K. K., Lloyd, J. M., Akpogheneta, O. J., Greenwood, B. M., Bojang, K. A. and Conway, D. J., Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J. Infect. Dis. 2007. 195: 279-287.
60. Roberts, D. J., Craig, A. G., Berendt, A. R., Pinches, R., Nash, G., Marsh, K. and Newbold, C. I., Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 1992. 357: 689-692.
61. Weiss, G. E., Ndungu, F. M., McKittrick, N., Li, S., Kimani, D., Crompton, P. D., Marsh, K. et al., High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections. J. Immunol. Methods 2012. 375: 68-74.